MarketCapExport financials
Stericycle (SRCL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Stericycle Balance Sheet 2023-2007 | SRCL
Brief overview of Stericycle's balance sheet structure
The comparison uses five available annual reports from the 2019–2023 interval.
Across five reporting periods, assets decreased -16.8%, from $6.4 billion to $5.4 billion, producing a negative trend.
Assets outpaced liabilities, -16.8% versus -31%. Dependence on external funding declined.
The share of internal funding stands at 47.1% versus 36.2% initially, providing a reasonable foundation.
Net debt is $1.4 billion, or 0.54x of equity. This is a conservative debt position.
Cash equals 0.7% of the balance sheet, compared with 0.5% five periods ago. This is the readily available cushion.
Retained earnings reached $1.4 billion, changing -3.7% over the period. A positive accumulated result supports equity.
What the balance sheet shows
Stericycle's financial position is positive on balance sheet evidence. Growth in resources has not undermined capital strength.
Annual Balance Sheet Stericycle
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.36 B | 1.53 B | 1.63 B | 1.8 B | 2.71 B | 2.72 B | 2.7 B | 2.9 B | 3.14 B | 1.63 B | 1.36 B | 1.32 B | 1.36 B | 1.02 B | 973 M | - | - |
Long Term Debt |
1.29 B | 1.5 B | 1.6 B | 1.77 B | 2.65 B | 2.76 B | 2.74 B | 2.95 B | 3.2 B | 1.65 B | 1.42 B | 1.35 B | 1.38 B | 1.1 B | 989 M | - | - |
Long Term Debt Current |
105 M | 91.2 M | 85.5 M | 86.2 M | 94.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 3.35 B | 3.13 B | 3.11 B | 3.62 B | 3.74 B | 2.02 B | 1.7 B | 1.66 B | 1.62 B | - | - | - | - |
Total Current Liabilities |
718 M | 622 M | 732 M | 697 M | 757 M | 733 M | 969 M | 543 M | 587 M | 461 M | 416 M | 331 M | 327 M | 308 M | 233 M | - | - |
Total Liabilities |
2.83 B | 2.91 B | 3.07 B | 3.15 B | 4.1 B | 3.86 B | 4.08 B | 4.16 B | 4.33 B | 2.48 B | 2.12 B | 1.99 B | 1.95 B | - | - | - | - |
Deferred Revenue |
72.6 M | 7.9 M | 9 M | 8.8 M | 12.2 M | 15 M | 17.9 M | 17.9 M | 17 M | 21.6 M | 18.8 M | 18.1 M | 12.9 M | 14.5 M | 15 M | - | - |
Retained Earnings |
1.39 B | 1.41 B | 1.35 B | 1.38 B | 1.44 B | 1.79 B | 2.03 B | 2.01 B | 1.87 B | 1.74 B | 1.61 B | 1.46 B | 1.24 B | 1.02 B | 810 M | - | - |
Total Assets |
5.35 B | 5.33 B | 5.47 B | 5.58 B | 6.44 B | 6.46 B | 6.99 B | 6.98 B | 7.07 B | 4.37 B | 3.89 B | 3.55 B | 3.18 B | 2.64 B | 2.18 B | 1.76 B | - |
Cash and Cash Equivalents |
35.3 M | 56 M | 55.6 M | 53.3 M | 34.7 M | 34.3 M | 42.2 M | 44.2 M | 55.6 M | 22.2 M | 67.2 M | 34.7 M | 22.5 M | 79.3 M | 15.8 M | 9.1 M | 17.1 M |
Book Value |
2.52 B | 2.42 B | 2.4 B | 2.43 B | 2.33 B | 2.6 B | 2.91 B | 2.82 B | 2.74 B | 1.89 B | 1.77 B | 1.56 B | 1.23 B | 2.64 B | 2.18 B | 1.76 B | - |
Total Shareholders Equity |
2.52 B | 2.42 B | 2.4 B | 2.43 B | 2.33 B | 2.59 B | 2.9 B | 2.81 B | 2.73 B | 1.9 B | 1.75 B | 1.54 B | 1.2 B | 1.05 B | 846 M | 671 M | 714 M |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Stericycle
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.36 B | 1.39 B | 1.4 B | 1.28 B | 1.3 B | 1.29 B | 1.49 B | 1.48 B | 1.65 B | 1.68 B | 1.68 B | 1.59 B | 1.62 B | 1.6 B | 1.65 B | 1.77 B | 1.88 B | 2 B | 2.52 B | 2.65 B | 2.62 B | 2.7 B | 2.7 B | 2.76 B | 2.72 B | 2.54 B | 2.59 B | 2.74 B | 2.63 B | 2.75 B | 2.77 B | 2.95 B | 2.92 B | 3.01 B | 3.04 B | 3.2 B | 1.41 B | 1.54 B | 1.46 B | 1.65 B | 1.51 B | 1.56 B | 1.25 B | 1.42 B | 1.3 B | 1.25 B | 1.19 B | 1.35 B | 1.01 B | 1.28 B | 1.25 B | 1.38 B | 1.3 B | 1.17 B | 1.01 B | 880 M | 859 M |
Total Liabilities |
2.93 B | 2.94 B | 2.91 B | 2.83 B | 2.77 B | 2.73 B | 2.89 B | 2.91 B | 3.01 B | 3.05 B | 3.1 B | 3.07 B | 3.05 B | 3.02 B | 3.08 B | 3.15 B | 3.29 B | 3.39 B | 4.07 B | 4.1 B | 4.2 B | 4.31 B | 4.28 B | 3.86 B | 3.97 B | 4.01 B | 4.06 B | 4.08 B | 4.08 B | 4.08 B | 4.08 B | 4.16 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
80.4 M | 79.7 M | 70.1 M | 72.6 M | 65.1 M | 8.2 M | 8.7 M | 7.9 M | 8.2 M | 9.5 M | 9.3 M | 9 M | 8.7 M | 9.7 M | 9.8 M | 8.8 M | 9.5 M | 9.5 M | 9.8 M | 12.2 M | 13.4 M | 14.5 M | 13.5 M | 15 M | 15.5 M | 17.4 M | 18.1 M | 17.9 M | 19.1 M | 19.2 M | 18 M | 17.9 M | 15.5 M | 17.1 M | 17.5 M | 17 M | 18.2 M | 18.6 M | 20.3 M | 21.6 M | 22.4 M | 22.4 M | 22 M | 18.8 M | 19.5 M | 18.2 M | 16.8 M | 18.1 M | 15.2 M | 16 M | 13.9 M | 12.9 M | 13.7 M | 14.2 M | 14.7 M | 16.9 M | 16.6 M |
Retained Earnings |
1.39 B | 1.41 B | 1.4 B | 1.39 B | 1.37 B | 1.37 B | 1.42 B | 1.41 B | 1.38 B | 1.35 B | 1.34 B | 1.35 B | 1.37 B | 1.44 B | 1.41 B | 1.38 B | 1.33 B | 1.42 B | 1.42 B | 1.44 B | 1.66 B | 1.72 B | 1.75 B | 1.79 B | 2.11 B | 2.09 B | 2.06 B | 2.03 B | 1.95 B | 1.91 B | 2.06 B | 2.01 B | 1.99 B | 1.93 B | 1.9 B | 1.87 B | 1.83 B | 1.79 B | 1.81 B | 1.74 B | 1.69 B | 1.63 B | 1.61 B | 1.61 B | 1.58 B | 1.55 B | 1.53 B | 1.46 B | 1.43 B | 1.37 B | 1.31 B | 1.24 B | 1.19 B | 1.13 B | 1.07 B | 968 M | 911 M |
Total Assets |
5.48 B | 5.48 B | 5.44 B | 5.35 B | 5.25 B | 5.21 B | 5.33 B | 5.33 B | 5.34 B | 5.41 B | 5.48 B | 5.47 B | 5.47 B | 5.52 B | 5.53 B | 5.58 B | 5.63 B | 5.69 B | 6.35 B | 6.44 B | 6.68 B | 6.87 B | 6.85 B | 6.46 B | 6.9 B | 6.91 B | 7.02 B | 6.99 B | 7.02 B | 7.04 B | 7 B | 6.98 B | 7.06 B | 7.15 B | 7.11 B | 7.07 B | 5.18 B | 4.53 B | 4.38 B | 4.37 B | 4.45 B | 4.44 B | 3.87 B | 3.89 B | 3.85 B | 3.62 B | 3.54 B | 3.55 B | 3.41 B | 3.34 B | 3.28 B | 3.18 B | 3.16 B | 2.97 B | 2.64 B | 2.43 B | 2.3 B |
Cash and Cash Equivalents |
34.3 M | 34.9 M | 31 M | 35.3 M | 29.7 M | 30.7 M | 60 M | 56 M | 44 M | 45.9 M | 59.6 M | 55.6 M | 37.5 M | 61.7 M | 50 M | 53.3 M | 59.4 M | 42 M | 36 M | 34.7 M | 30.8 M | 34.5 M | 48.2 M | 34.3 M | 52 M | 45 M | 49.4 M | 42.2 M | 52.2 M | 44.2 M | 47 M | 44.2 M | 40.3 M | 44.3 M | 45.7 M | 55.6 M | 32.9 M | 33 M | 38.3 M | 22.2 M | 42 M | 25.3 M | 43.1 M | 67.2 M | 63.6 M | 18 M | 12.7 M | 34.7 M | 16.2 M | 54.2 M | 30.3 M | 22.5 M | 23.4 M | 38.2 M | 24.7 M | 20.6 M | 8.25 M |
Book Value |
2.55 B | 2.53 B | 2.52 B | 2.52 B | 2.48 B | 2.48 B | 2.45 B | 2.42 B | 2.33 B | 2.35 B | 2.38 B | 2.4 B | 2.42 B | 2.49 B | 2.45 B | 2.43 B | 2.34 B | 2.3 B | 2.28 B | 2.33 B | 2.48 B | 2.56 B | 2.57 B | 2.6 B | 2.93 B | 2.9 B | 2.95 B | 2.91 B | 2.94 B | 2.96 B | 2.92 B | 2.82 B | 7.06 B | 7.15 B | 7.11 B | 7.07 B | 5.18 B | 4.53 B | 4.38 B | 4.37 B | 4.45 B | 4.44 B | 3.87 B | 3.89 B | 3.85 B | 3.62 B | 3.54 B | 3.55 B | 3.41 B | 3.34 B | 3.28 B | 3.18 B | 3.16 B | 2.97 B | 2.64 B | 2.43 B | 2.3 B |
Total Shareholders Equity |
2.55 B | 2.53 B | 2.52 B | 2.52 B | 2.48 B | 2.48 B | 2.45 B | 2.42 B | 2.32 B | 2.35 B | 2.38 B | 2.4 B | 2.42 B | 2.49 B | 2.45 B | 2.43 B | 2.33 B | 2.29 B | 2.28 B | 2.33 B | 2.47 B | 2.56 B | 2.57 B | 2.59 B | 2.92 B | 2.89 B | 2.94 B | 2.9 B | 2.81 B | 2.75 B | 2.88 B | 2.81 B | 2.85 B | 2.82 B | 2.81 B | 2.73 B | 2.72 B | 1.96 B | 1.93 B | 1.9 B | 1.86 B | 1.83 B | 1.77 B | 1.75 B | 1.71 B | 1.63 B | 1.61 B | 1.54 B | 1.48 B | 1.37 B | 1.3 B | 1.2 B | 1.18 B | 1.22 B | 1.15 B | 1.02 B | 949 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Stericycle, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
